Christopher van Tuyl is CLO at Immunovant, Inc. (IMVT). They have made 8 open-market trades across 1 company since 2025, most recently 2026-10-07.
CIK 0001779707
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMVT | 175,218 | $4.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2026-10-07 | 2026-10-09 | $32.06 | $43K | — | — | — |
| IMVT | SELL | 2026-09-23 | 2026-09-25 | $36.36 | $103K | -2.6% | — | — |
| IMVT | SELL | 2026-07-08 | 2026-07-10 | $39.55 | $48K | +3.2% | +5.1% | -20.1% |
| IMVT | SELL | 2026-06-26 | 2026-06-26 | $38.31 | $683K | +6.4% | +3.8% | -11.9% |
| IMVT | SELL | 2026-06-18 | 2026-06-22 | $35.39 | $93K | +2.0% | +2.8% | -2.2% |
| IMVT | SELL | 2026-04-08 | 2026-04-10 | $24.83 | $128K | +20.7% | +19.0% | +68.2% |
| IMVT | SELL | 2026-03-18 | 2026-03-20 | $24.97 | $72K | +8.1% | +22.9% | +52.3% |
| IMVT | SELL | 2025-12-18 | 2025-12-19 | $26.91 | $582K | -2.7% | -1.8% | -11.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.